These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3003804)

  • 21. Platelet imipramine binding in depressed children and adolescents.
    Ambrosini PJ; Metz C; Arora RC; Lee JC; Kregel L; Meltzer HY
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):298-305. PubMed ID: 1314256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imipramine binding as a predictor of fluoxetine response in depressed patients.
    Castrogiovanni P; Di Muro A; Marazziti D
    Neuropsychobiology; 1995; 31(2):64-7. PubMed ID: 7760987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors.
    Poirier MF; Benkelfat C; Loo H; Sechter D; Zarifian E; Galzin AM; Langer SZ
    Psychopharmacology (Berl); 1986; 89(4):456-61. PubMed ID: 3092276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and treatment effects on 3H-clonidine and 3H-imipramine binding in elderly depressed patients.
    Georgotas A; Schweitzer J; McCue RE; Armour M; Friedhoff AJ
    Life Sci; 1987 Jun; 40(22):2137-43. PubMed ID: 3035303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet [3H]imipramine and [3H]paroxetine binding in depressed patients.
    Rosel P; Menchón JM; Vallejo J; Arranz B; Navarro MA; Lirón F; Alvarez P
    J Affect Disord; 1997 Jun; 44(1):79-85. PubMed ID: 9186805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seasonal variation of imipramine binding in the blood platelets of normal controls and depressed patients.
    Arora RC; Meltzer HY
    Biol Psychiatry; 1988 Feb; 23(3):217-26. PubMed ID: 2827795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of phototherapy on 3H-imipramine binding sites in patients with SAD, non-SAD and in healthy controls.
    Szádóczky E; Falus A; Németh A; Teszéri G; Moussong-Kovács E
    J Affect Disord; 1991 Aug; 22(4):179-84. PubMed ID: 1658102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Why some depressed patients may have low platelet 3H-imipramine binding.
    Mellerup ET; Plenge P
    Acta Psychiatr Scand; 1990 Oct; 82(4):330-4. PubMed ID: 2175539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seasonal changes in cyanoimipramine specific platelet 3H-imipramine binding in depression.
    DeMet EM; Bell KM; Reist C; Gerner RH; Chicz-DeMet A
    Psychiatry Res; 1990 Dec; 34(3):315-29. PubMed ID: 1963694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet tritiated imipramine binding in psychiatric patients: relationship to symptoms and severity of depression.
    Ellis PM; McIntosh CJ; Beeston R; Salmond CE; Cooke RR; Mellsop G
    Acta Psychiatr Scand; 1990 Oct; 82(4):275-82. PubMed ID: 2175538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological markers in juvenile depression.
    Carstens ME; Engelbrecht AH; Russell VA; van Zyl AM; Taljaard JJ
    Psychiatry Res; 1988 Jan; 23(1):77-88. PubMed ID: 2834765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electroconvulsive shock therapy and maximum binding of platelet tritiated imipramine binding in depression.
    Langer SZ; Sechter D; Loo H; Raisman R; Zarifian E
    Arch Gen Psychiatry; 1986 Oct; 43(10):949-52. PubMed ID: 3019267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder.
    Wgner A; Montero D; Mårtensson B; Siwers B; Asberg M
    J Affect Disord; 1990 Oct; 20(2):101-13. PubMed ID: 2176228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circannual variations in the density of tritiated imipramine binding sites on blood platelets in man.
    Egrise D; Desmedt D; Schoutens A; Mendlewicz J
    Neuropsychobiology; 1983; 10(2-3):101-2. PubMed ID: 6325993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-affinity 3H-imipramine binding sites: a possible state-dependent marker for major depression.
    Marazziti D; Perugi G; Deltito J; Lenzi A; Maremmani I; Placidi GF; Cassano GB
    Psychiatry Res; 1988 Feb; 23(2):229-37. PubMed ID: 2834766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptine.
    Poirier MF; Galzin AM; Loo H; Pimoule C; Segonzac A; Benkelfat C; Sechter D; Zarifian E; Schoemaker H; Langer SZ
    Biol Psychiatry; 1987 Mar; 22(3):287-302. PubMed ID: 3028514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.
    Hrdina PD; Bakish D; Ravindran A; Chudzik J; Cavazzoni P; Lapierre YD
    Psychiatry Res; 1997 Feb; 66(2-3):73-85. PubMed ID: 9075272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.
    Langer SZ; Galzin AM; Poirier MF; Loo H; Sechter D; Zarifian E
    J Recept Res; 1987; 7(1-4):499-521. PubMed ID: 3040983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variation in human platelet 3H-imipramine binding.
    Tang SW; Morris JM
    Psychiatry Res; 1985 Oct; 16(2):141-6. PubMed ID: 3865254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered platelet 3H-imipramine binding in schizo-affective and depressive disorders.
    Suranyi-Cadotte BE; Wood PL; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Aug; 18(8):923-7. PubMed ID: 6311293
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.